References
- Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26.
- Kalejaiye O, Vij M, Drake MJ. Classification of stress urinary incontinence. World J Urol. 2015;33(9):1215–1220.
- Kayigil O, Iftekhar Ahmed S, Metin A. The coexistence of intrinsic sphincter deficiency with type II stress incontinence. J Urol. 1999;162(4):1365–1366.
- Erel CT, Inan D, Mut A. Predictive factors for the efficacy of Er: YAG laser treatment of urinary incontinence. Maturitas. 2020;132:1–6.
- Erel CT, Fernandez LDC, Inan D, et al. Er: YAG laser treatment of urinary incontinence after failed TOT/TVT procedures. Eur J Obstet Gynecol Reprod Biol. 2020;252:399–403.
- Erel CT, Fistonić I, Gambacciani M, et al. Er: YAG laser in hysterectomized women with stress urinary incontinence: a VELA retrospective cohort, non-inferiority study. Climacteric. 2020;23(sup1):S18–S23.
- Blaganje M, Šćepanović D, Žgur L, et al. Non-ablative Er: YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018;224:153–158.
- Fistonić N, Fistonić I, Guštek ŠF, et al. Minimally invasive, non-ablative Er: YAG laser treatment of stress urinary incontinence in women—a pilot study. Lasers Med Sci. 2016;31(4):635–643.
- Fistonić I, Fistonić N. Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er: YAG laser treatment in stress urinary incontinent women: a prospective cohort study. Lasers Surg Med. 2018;50(6):636–643.
- Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 2019;37(5):885–889.
- Gambacciani M, Levancini M, Russo E, et al. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21(2):148–152.
- Okui N, Miyazaki H, Takahashi W, et al. Comparison of urethral sling surgery and non-ablative vaginal Erbium: YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis. Lasers Med Sci. 2022;37(1):655–663.
- Gambacciani M, Cervigni M, Gaspar A, et al. Safety of vaginal erbium laser: a review of 113,000 patients treated in the past 8 years. Climacteric. 2020;23(sup1):S28–S32.
- Gaspar A, Brandi H. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency). Lasers Med Sci. 2017;32(3):685–691.
- Gaspar A, Maestri S, Silva J, et al. Intraurethral Erbium: YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Lasers Surg Med. 2018;50(8):802–807.
- Xu S F, Abulikim K, Wu XY, et al. Morphological and histological changes in the urethra after intraurethral nonablative erbium YAG laser therapy: an experimental study in beagle dogs. Lasers Med Sci. 2022;37(8):3137–3146.
- Gaspar A, Silva J, Calderon A, et al. Histological findings after non-ablative Er: YAG laser therapy in women with severe vaginal atrophy. Climacteric. 2020;23(sup1):S11–S13.
- Lapii GA, Yakovleva A, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary ıncontinence under conditions of Er: YAG laser treatment. Bull Exp Biol Med. 2017;162(4):510–514.
- Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017;49(2):137–159.
- Klarskov N, Lose G. Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn. 2008;27(8):789–792.
- Brosche T, Kuhn A, Lobodasch K, et al. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40(1):502–508.
- Erel T, Ozcivit IB. Vaginal laser therapy after hysterectomy and failed mid-urethral sling surgery. Içinde. In: Gambacciani M, Gaspar A, Gaviria J, editors. The laser essentıals the cookbook for functional gynecology and aesthetics. Torino: Edizioni Minerva Medica; 2022. p. 53–59.
- Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol. 2014;123(6):1403–1407.
- Nager CW, Brubaker L, Litman HJ, et al. A randomized trial of urodynamic testing before stress-ıncontinence surgery. N Engl J Med. 2012;366(21):1987–1997.
- Sirls LT, Richter HE, Litman HJ, et al. The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary ıncontinence surgery. J Urol. 2013;189(1):204–209.
- van Leijsen SAL, Kluivers KB, Mol BWJ, et al. Value of urodynamics before stress urinary ıncontinence surgery. Obstet Gynecol. 2013;121(5):999–1008.
- van Leijsen SAL, Kluivers KB, Mol BWJ, et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn. 2012;31(7):1118–1123.
- Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary ıncontinence: AUA/SUFU guideline. J Urol. 2017;198(4):875–883.
- Ruffolo AF, Casiraghi A, Marotta E, et al. Does the time of onset of urinary symptoms affect microablative fractional CO2 laser efficacy in postmenopausal women? Lasers Surg Med. 2021;53(7):953–959.